Analysis of creatine kinase activity in 504 patients with proximal spinal muscular atrophy types I-III from the point of view of progression and severity

European Neurology

Volumn 39, Issue 3, 1998, Pages 154-162

  Rudnik Schöneborn, Sabine ^a,c   Lützenrath, Susanne ^a   Borkowska, Janina ^b   Karwanska, Anna ^b   Hausmanowa Petrusewicz, Irena ^b   Zerres, Klaus ^a  

^a UNIVERSITY OF BONN   (Germany)

^b POLISH ACADEMY OF SCIENCES   (Poland)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Creatine kinase activity; Progression; Proximal spinal muscular atrophy; Severity

Indexed keywords

CREATINE KINASE;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHILD; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOTONEURON; NEWBORN; ONSET AGE; PRIORITY JOURNAL; PUBERTY; SEX DIFFERENCE; SPINAL MUSCULAR ATROPHY; STATISTICAL MODEL; TELOMERE;

ADOLESCENT; ADULT; AGE OF ONSET; CREATINE KINASE; DISEASE PROGRESSION; FEMALE; GENE DELETION; HUMANS; MALE; MOVEMENT; MUSCULAR ATROPHY, SPINAL; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 2642653227     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007926     Document Type: Article

References (23)

1. Heyck H, Laudahn G: Muscle and serum enzymes in muscular dystrophy and neurogenic muscular atrophy; in Milhorat AT (ed): Exploratory Concepts in Muscular Dystrophy and Related Disorders. Excerpta Med, Int Congr Ser, Amsterdam 1967;147:232-240.
2. Hausmanowa-Petrusewicz I, Askanas W, Badurska B, Emeryk B, Fidzianska A, Garbalinska W, Hetnarska L, Jedrezejowska H, Kamieniecka Z, Niebroj-Dobosz I, Prot J, Sawicka E: Infantile and juvenile spinal muscular atrophy. J Neurol Sci 1968;6:269-287.
3. Hetnarska L, Prot J, Sawicka E: Creatine phosphokinase activity in spinal muscular atrophy. J Neurol Sci 1968;6:261-267.
4. Van Wijngaarden GK, Bethlem J: Benign infantile spinal muscular atrophy. A prospective study. Brain 1973;96:163-170.
5. Dorsher PT, Sinaki M, Mulder DW, Litchy WJ, Ilstrup DM: Wohlfart-Kugelberg-Welander syndrome: Serum creatine kinase and functional outcome. Arch Phys Med Rehabil 1991; 72:587-591.
6. Gamstorp I: Progressive spinal muscular atrophy with onset in infancy or early childhood. Acta Paediatr Scand 1967;56:408-423.
7. Bouwsma G, van Wijngaarden GK: Spinal muscular atrophy and hypertrophy of the calves. J Neurol Sci 1980;44:275-279.
8. Hausmanowa-Petrusewicz I: Spinal Muscular Atrophy, Infantile and Juvenile Type. Springfield, National Library of Medicine, 1978.
9. International SMA Consortium: Meeting report. Neuromusc Disord 1992;2:423-428.
10. Zerres K, Rudnik-Schöneborn S: Natural history of proximal spinal muscular atrophy. Arch Neurol 1995;52:518-523.
11. Zerres K, Rudnik-Schöneborn S, Borkowska J, Forrest E, Lusakowska A, Hausmanowa-Petrusewicz I: Collaborative study on the natural history of patients with childhood and juvenile onset spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci 1997;146:67-72.
12. Gale AN, Murphy EA: The use of serum creatine phosphokinase in genetic counseling for Duchenne muscular dystrophy. J Chronic Dis 1978;31:101-109.
13. Szasz G, Busch E-W, Farohs H-B: Serum-Kreatinkinase. Dt Med Wochenschr 1970;95:829-835.
14. Wiesmann U, Colombo JP, Adam A, Richterich R: Determination of cysteine activated creatine kinase in serum. Enzym Biol Clin 1966;7:266-284.
15. Harris EK, Wong ET, Shaw ST: Statistical criteria for separate reference intervals: Race and gender groups in creatine kinase. Clin Chem 1991;37:1580-1582.
16. Hay WL: Statistics, ed. 4. Orlando, Holt, Rinehart & Winston, 1988.
17. Hüsler J, Zimmermann H: Statistische Prinzipien für medizinische Projekte, ed 2. Bern, Huber, 1996.
18. Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, Le Paslier D, Frézal J, Cohen D, Weissenbach J, Munnich A, Melki J: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155-165.
19. Hahnen E, Forkert R, Marke C, Rudnik-Schöneborn S, Schönling J, Zerres K, Wirth B: Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: Evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet 1995;4:1927-1933.
20. Miller WG, Chinchilli VM, Gruemer H-D, Nance WE: Sampling from a skewed population distribution as exemplified by estimation of the creatine kinase upper reference limit. Clin Chem 1984;30:18-23.
21. Zerres K, Rudnik-Schöneborn S, Rietschel M: Heterogeneity in proximal spinal muscular atrophy. Lancet 1989;336:749-750.
22. Wong ET, Cobb C, Umehara MK, Wolff GA, Haywood LJ, Greenberg T, Shaw ST: Heterogeneity of serum creatine kinase activity among racial and gender groups of the population. Am J Clin Pathol 1983;79:582-586.
23. Hausmanowa-Petrusewicz I, Zaremba J, Borkowska J, Szirkowiec W: Chronic proximal spinal muscular atrophy of childhood and adolescence: Sex influence. J Med Genet 1984;21: 447-450.